Vincerx Pharma, Inc.
VINC
$0.049
-$0.006-10.91%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.99M | -7.84M | -1.81M | -12.43M | -4.95M |
| Total Depreciation and Amortization | 281.00K | 275.00K | 270.00K | 264.00K | 258.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 78.00K | 1.64M | -4.42M | 5.73M | 489.00K |
| Change in Net Operating Assets | 1.45M | -451.00K | 125.00K | -1.31M | -3.82M |
| Cash from Operations | -6.18M | -6.38M | -5.83M | -7.74M | -8.02M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.18M | 1.37M | -8.34M | -- | 5.75M |
| Cash from Investing | 7.18M | 1.37M | -8.34M | -- | 5.75M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 985.00K | 0.00 | 17.00M | 5.00K | 18.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 985.00K | 0.00 | 17.00M | 5.00K | 18.00K |
| Foreign Exchange rate Adjustments | 60.00K | 27.00K | -24.00K | 72.00K | -43.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.04M | -4.98M | 2.81M | -7.66M | -2.29M |